In this study, we observed a positive correlation between STAT2 and SLC27A3 expression in ccRCC and established a stable pazopanib-resistant 786-O cell line (786-O-PR) with up-regulated SLC27A3. Here, SLC27A3 is linked to nonpapillary renal cell carcinoma.